img

Global Human Immune Globulin Intravenous Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Immune Globulin Intravenous Market Research Report 2024

Immune globulin (Ig) short-term protection against hepatitis A and measles
According to Mr Accuracy reports new survey, global Human Immune Globulin Intravenous market is projected to reach US$ 21770 million in 2029, increasing from US$ 13360 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Immune Globulin Intravenous market research.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Immune Globulin Intravenous market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder

Segment by Application


Immunodeficiency
Autoimmune Disease
Acute Infection

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Immune Globulin Intravenous report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Human Immune Globulin Intravenous Market Overview
1.1 Product Overview and Scope of Human Immune Globulin Intravenous
1.2 Human Immune Globulin Intravenous Segment by Type
1.2.1 Global Human Immune Globulin Intravenous Market Value Comparison by Type (2024-2034)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Human Immune Globulin Intravenous Segment by Application
1.3.1 Global Human Immune Globulin Intravenous Market Value by Application: (2024-2034)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Human Immune Globulin Intravenous Market Size Estimates and Forecasts
1.4.1 Global Human Immune Globulin Intravenous Revenue 2018-2029
1.4.2 Global Human Immune Globulin Intravenous Sales 2018-2029
1.4.3 Global Human Immune Globulin Intravenous Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Immune Globulin Intravenous Market Competition by Manufacturers
2.1 Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2018-2024)
2.2 Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Human Immune Globulin Intravenous Average Price by Manufacturers (2018-2024)
2.4 Global Human Immune Globulin Intravenous Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Human Immune Globulin Intravenous, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Immune Globulin Intravenous, Product Type & Application
2.7 Human Immune Globulin Intravenous Market Competitive Situation and Trends
2.7.1 Human Immune Globulin Intravenous Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Immune Globulin Intravenous Players Market Share by Revenue
2.7.3 Global Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Immune Globulin Intravenous Retrospective Market Scenario by Region
3.1 Global Human Immune Globulin Intravenous Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Immune Globulin Intravenous Global Human Immune Globulin Intravenous Sales by Region: 2018-2029
3.2.1 Global Human Immune Globulin Intravenous Sales by Region: 2018-2024
3.2.2 Global Human Immune Globulin Intravenous Sales by Region: 2024-2029
3.3 Global Human Immune Globulin Intravenous Global Human Immune Globulin Intravenous Revenue by Region: 2018-2029
3.3.1 Global Human Immune Globulin Intravenous Revenue by Region: 2018-2024
3.3.2 Global Human Immune Globulin Intravenous Revenue by Region: 2024-2029
3.4 North America Human Immune Globulin Intravenous Market Facts & Figures by Country
3.4.1 North America Human Immune Globulin Intravenous Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Immune Globulin Intravenous Sales by Country (2018-2029)
3.4.3 North America Human Immune Globulin Intravenous Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Human Immune Globulin Intravenous Market Facts & Figures by Country
3.5.1 Europe Human Immune Globulin Intravenous Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Immune Globulin Intravenous Sales by Country (2018-2029)
3.5.3 Europe Human Immune Globulin Intravenous Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Immune Globulin Intravenous Market Facts & Figures by Country
3.6.1 Asia Pacific Human Immune Globulin Intravenous Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Immune Globulin Intravenous Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Immune Globulin Intravenous Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Immune Globulin Intravenous Market Facts & Figures by Country
3.7.1 Latin America Human Immune Globulin Intravenous Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Immune Globulin Intravenous Sales by Country (2018-2029)
3.7.3 Latin America Human Immune Globulin Intravenous Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Immune Globulin Intravenous Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Immune Globulin Intravenous Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Immune Globulin Intravenous Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Immune Globulin Intravenous Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Immune Globulin Intravenous Sales by Type (2018-2029)
4.1.1 Global Human Immune Globulin Intravenous Sales by Type (2018-2024)
4.1.2 Global Human Immune Globulin Intravenous Sales by Type (2024-2029)
4.1.3 Global Human Immune Globulin Intravenous Sales Market Share by Type (2018-2029)
4.2 Global Human Immune Globulin Intravenous Revenue by Type (2018-2029)
4.2.1 Global Human Immune Globulin Intravenous Revenue by Type (2018-2024)
4.2.2 Global Human Immune Globulin Intravenous Revenue by Type (2024-2029)
4.2.3 Global Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2029)
4.3 Global Human Immune Globulin Intravenous Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Immune Globulin Intravenous Sales by Application (2018-2029)
5.1.1 Global Human Immune Globulin Intravenous Sales by Application (2018-2024)
5.1.2 Global Human Immune Globulin Intravenous Sales by Application (2024-2029)
5.1.3 Global Human Immune Globulin Intravenous Sales Market Share by Application (2018-2029)
5.2 Global Human Immune Globulin Intravenous Revenue by Application (2018-2029)
5.2.1 Global Human Immune Globulin Intravenous Revenue by Application (2018-2024)
5.2.2 Global Human Immune Globulin Intravenous Revenue by Application (2024-2029)
5.2.3 Global Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2029)
5.3 Global Human Immune Globulin Intravenous Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Takeda Human Immune Globulin Intravenous Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Grifols Human Immune Globulin Intravenous Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.3.4 CSL Human Immune Globulin Intravenous Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Octapharma Human Immune Globulin Intravenous Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Biotest Human Immune Globulin Intravenous Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Kedrion Human Immune Globulin Intravenous Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hualan Bio Human Immune Globulin Intravenous Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.8.4 CNBG Human Immune Globulin Intravenous Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Shanghai RAAS Human Immune Globulin Intravenous Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.10.4 CBPO Human Immune Globulin Intravenous Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Human Immune Globulin Intravenous Description and Business Overview
6.11.3 LFB Group Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.11.4 LFB Group Human Immune Globulin Intravenous Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Human Immune Globulin Intravenous Description and Business Overview
6.12.3 BPL Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.12.4 BPL Human Immune Globulin Intravenous Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Immune Globulin Intravenous Industry Chain Analysis
7.2 Human Immune Globulin Intravenous Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Immune Globulin Intravenous Production Mode & Process
7.4 Human Immune Globulin Intravenous Sales and Marketing
7.4.1 Human Immune Globulin Intravenous Sales Channels
7.4.2 Human Immune Globulin Intravenous Distributors
7.5 Human Immune Globulin Intravenous Customers
8 Human Immune Globulin Intravenous Market Dynamics
8.1 Human Immune Globulin Intravenous Industry Trends
8.2 Human Immune Globulin Intravenous Market Drivers
8.3 Human Immune Globulin Intravenous Market Challenges
8.4 Human Immune Globulin Intravenous Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Immune Globulin Intravenous Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Human Immune Globulin Intravenous Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Human Immune Globulin Intravenous Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Immune Globulin Intravenous Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Human Immune Globulin Intravenous Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Human Immune Globulin Intravenous Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Human Immune Globulin Intravenous, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Human Immune Globulin Intravenous, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Immune Globulin Intravenous, Product Type & Application
Table 12. Global Key Manufacturers of Human Immune Globulin Intravenous, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Immune Globulin Intravenous by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immune Globulin Intravenous as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Immune Globulin Intravenous Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Immune Globulin Intravenous Sales by Region (2018-2024) & (K Units)
Table 18. Global Human Immune Globulin Intravenous Sales Market Share by Region (2018-2024)
Table 19. Global Human Immune Globulin Intravenous Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Immune Globulin Intravenous Sales Market Share by Region (2024-2029)
Table 21. Global Human Immune Globulin Intravenous Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2018-2024)
Table 23. Global Human Immune Globulin Intravenous Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2024-2029)
Table 25. North America Human Immune Globulin Intravenous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 27. North America Human Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Immune Globulin Intravenous Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Human Immune Globulin Intravenous Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Immune Globulin Intravenous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 32. Europe Human Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Immune Globulin Intravenous Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Human Immune Globulin Intravenous Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Immune Globulin Intravenous Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Immune Globulin Intravenous Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Human Immune Globulin Intravenous Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Immune Globulin Intravenous Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Human Immune Globulin Intravenous Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Immune Globulin Intravenous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Human Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Immune Globulin Intravenous Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Human Immune Globulin Intravenous Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Immune Globulin Intravenous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Human Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Immune Globulin Intravenous Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Human Immune Globulin Intravenous Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Immune Globulin Intravenous Sales (K Units) by Type (2018-2024)
Table 51. Global Human Immune Globulin Intravenous Sales (K Units) by Type (2024-2029)
Table 52. Global Human Immune Globulin Intravenous Sales Market Share by Type (2018-2024)
Table 53. Global Human Immune Globulin Intravenous Sales Market Share by Type (2024-2029)
Table 54. Global Human Immune Globulin Intravenous Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Human Immune Globulin Intravenous Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2024)
Table 57. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2024-2029)
Table 58. Global Human Immune Globulin Intravenous Price (USD/Unit) by Type (2018-2024)
Table 59. Global Human Immune Globulin Intravenous Price (USD/Unit) by Type (2024-2029)
Table 60. Global Human Immune Globulin Intravenous Sales (K Units) by Application (2018-2024)
Table 61. Global Human Immune Globulin Intravenous Sales (K Units) by Application (2024-2029)
Table 62. Global Human Immune Globulin Intravenous Sales Market Share by Application (2018-2024)
Table 63. Global Human Immune Globulin Intravenous Sales Market Share by Application (2024-2029)
Table 64. Global Human Immune Globulin Intravenous Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Human Immune Globulin Intravenous Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2024)
Table 67. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2024-2029)
Table 68. Global Human Immune Globulin Intravenous Price (USD/Unit) by Application (2018-2024)
Table 69. Global Human Immune Globulin Intravenous Price (USD/Unit) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Takeda Human Immune Globulin Intravenous Product
Table 74. Takeda Recent Developments/Updates
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Grifols Human Immune Globulin Intravenous Product
Table 79. Grifols Recent Developments/Updates
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. CSL Human Immune Globulin Intravenous Product
Table 84. CSL Recent Developments/Updates
Table 85. Octapharma Corporation Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Octapharma Human Immune Globulin Intravenous Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Biotest Corporation Information
Table 91. Biotest Description and Business Overview
Table 92. Biotest Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Biotest Human Immune Globulin Intravenous Product
Table 94. Biotest Recent Developments/Updates
Table 95. Kedrion Corporation Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Kedrion Human Immune Globulin Intravenous Product
Table 99. Kedrion Recent Developments/Updates
Table 100. Hualan Bio Corporation Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Hualan Bio Human Immune Globulin Intravenous Product
Table 104. Hualan Bio Recent Developments/Updates
Table 105. CNBG Corporation Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. CNBG Human Immune Globulin Intravenous Product
Table 109. CNBG Recent Developments/Updates
Table 110. Shanghai RAAS Corporation Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Shanghai RAAS Human Immune Globulin Intravenous Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. CBPO Corporation Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. CBPO Human Immune Globulin Intravenous Product
Table 119. CBPO Recent Developments/Updates
Table 120. LFB Group Corporation Information
Table 121. LFB Group Description and Business Overview
Table 122. LFB Group Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. LFB Group Human Immune Globulin Intravenous Product
Table 124. LFB Group Recent Developments/Updates
Table 125. BPL Corporation Information
Table 126. BPL Description and Business Overview
Table 127. BPL Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. BPL Human Immune Globulin Intravenous Product
Table 129. BPL Recent Developments/Updates
Table 130. Sichuan Yuanda Shuyang Corporation Information
Table 131. Sichuan Yuanda Shuyang Description and Business Overview
Table 132. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product
Table 134. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Human Immune Globulin Intravenous Distributors List
Table 138. Human Immune Globulin Intravenous Customers List
Table 139. Human Immune Globulin Intravenous Market Trends
Table 140. Human Immune Globulin Intravenous Market Drivers
Table 141. Human Immune Globulin Intravenous Market Challenges
Table 142. Human Immune Globulin Intravenous Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Immune Globulin Intravenous
Figure 2. Global Human Immune Globulin Intravenous Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Human Immune Globulin Intravenous Market Share by Type in 2022 & 2029
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Human Immune Globulin Intravenous Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Human Immune Globulin Intravenous Market Share by Application in 2022 & 2029
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Global Human Immune Globulin Intravenous Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Human Immune Globulin Intravenous Market Size (2018-2029) & (US$ Million)
Figure 13. Global Human Immune Globulin Intravenous Sales (2018-2029) & (K Units)
Figure 14. Global Human Immune Globulin Intravenous Average Price (USD/Unit) & (2018-2029)
Figure 15. Human Immune Globulin Intravenous Report Years Considered
Figure 16. Human Immune Globulin Intravenous Sales Share by Manufacturers in 2022
Figure 17. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Human Immune Globulin Intravenous Players: Market Share by Revenue in 2022
Figure 19. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Human Immune Globulin Intravenous Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Human Immune Globulin Intravenous Sales Market Share by Country (2018-2029)
Figure 22. North America Human Immune Globulin Intravenous Revenue Market Share by Country (2018-2029)
Figure 23. the United States Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Human Immune Globulin Intravenous Sales Market Share by Country (2018-2029)
Figure 26. Europe Human Immune Globulin Intravenous Revenue Market Share by Country (2018-2029)
Figure 27. Germany Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. UK Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Human Immune Globulin Intravenous Revenue Market Share by Region (2018-2029)
Figure 34. China Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Human Immune Globulin Intravenous Sales Market Share by Country (2018-2029)
Figure 44. Latin America Human Immune Globulin Intravenous Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Human Immune Globulin Intravenous Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Human Immune Globulin Intravenous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Human Immune Globulin Intravenous by Type (2018-2029)
Figure 54. Global Revenue Market Share of Human Immune Globulin Intravenous by Type (2018-2029)
Figure 55. Global Human Immune Globulin Intravenous Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Human Immune Globulin Intravenous by Application (2018-2029)
Figure 57. Global Revenue Market Share of Human Immune Globulin Intravenous by Application (2018-2029)
Figure 58. Global Human Immune Globulin Intravenous Price (USD/Unit) by Application (2018-2029)
Figure 59. Human Immune Globulin Intravenous Value Chain
Figure 60. Human Immune Globulin Intravenous Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed